Franklin Genomic Advancement Fund

Franklin Genomic Advancement Fund is a unique exchange-traded fund (ETF) designed to provide investors with exposure to companies involved in genomic sciences and advancements. This ETF focuses on entities actively contributing to and benefiting from innovations in gene editing, gene therapy, and DNA sequencing technologies. By targeting a niche segment within the healthcare and biotechnology industries, the fund enables investors to participate in the growth opportunities presented by breakthroughs in genetic research and its commercial applications. The fund includes a diverse portfolio of companies ranging from established pharmaceutical giants to emerging biotech firms, all at the forefront of genomics. The Franklin Genomic Advancement Fund plays a significant role in the market by offering a specialized investment avenue within the ever-evolving domain of genomic science, appealing to those interested in supporting and capitalizing on the technological advancements shaping the future of healthcare.